Myocor
Latest round
- Series D
Last raised
- Dec 2004
Total raised
- $24M
Investors
- 8
About Myocor
Myocor® Inc.Myocor® Inc. was founded in 1996 in Maple Grove, US, and specializes in developing devices for treating mitral insufficiency through the Coapsys® System. The company was acquired by Edwards Lifesciences Corporation in October 2008, marking a significant pivot in its operational strategy. The founder's previous endeavors are not detailed.Myocor® Inc. specializes in developing innovative therapeutic devices aimed at optimizing treatment options for patients with heart diseases related to geometrically remodeled hearts. Their core offering includes the Coapsys® System, a device specifically designed for the treatment of mitral insufficiency, which addresses the complex geometric changes that occur in the heart's structure. This technology, characterized by its proprietary Shape Change Therapy, aims to restore cardiac function by modifying the heart's geometry, thereby improving patient outcomes.Myocor® Inc. generates revenue through direct sales of its flagship Coapsys® System to healthcare institutions and surgical centers specializing in cardiac care. The business model is primarily B2B, engaging directly with hospital networks and cardiology clinics, which integrate these therapeutic devices into their treatment protocols. Revenue transactions typically involve upfront payments for the devices, along with potential ongoing service agreements for maintenance and support. Additionally, the company may engage in partnerships with healthcare providers to facilitate training and implementation of their systems, further establishing their presence in the cardiac treatment market.As of now, Myocor® Inc. has not publicly disclosed specific upcoming products or new geographic markets targeted for expansion.00 mn in 2008, was utilized to support their operational growth and product development strategies, although specific details on new product launches or market entry timelines remain unspecified.
Who invested in Myocor
8 investors across 1 round
See all investors in Myocor
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Dec 21, 2004
Amount
$24M
Investors
Questions about Myocor
Who invested in Myocor?
Myocor has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Myocor raised?
Myocor has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Myocor last raise money?
Myocor's most recent round on record is a Series D, in Dec 2004.
What does Myocor do?
Myocor is a healthcare company.
Where is Myocor headquartered?
Myocor is headquartered in Maple Grove, US.
Which VCs invest in companies like Myocor?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Myocor's stage. Their profiles are linked below.
VCs backing healthcare startups at Series D
Raising like Myocor? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.